Zahra Goodarzi1, Zahinoor Ismail1. 1. Department of Medicine, Section of Geriatric Medicine (ZG), Department of Psychiatry (ZI), and Department of Clinical Neurosciences (ZI), University of Calgary and Alberta Health Services; and the Hotchkiss Brain Institute (ZI) and The Mathison Centre for Mental Health Research and Education (ZI), University of Calgary, Canada.
Abstract
PURPOSE OF REVIEW: To review the available evidence for the detection and management of depression in Parkinson disease (PD) and dementia. RECENT FINDINGS: Depression is a common comorbidity in those with PD or dementia, and leads to increased morbidity. There are several available and accurate tools for the detection of depression in PD (e.g., Geriatric Depression Scale) and dementia (e.g., Cornell Scale for Depression in Dementia). Treatment of depression depends on patient preference, severity of depression, comorbidities, and available resources. Despite variable evidence, the use of nonpharmacologic strategies to manage depression is suggested. Pharmacologic management is guided by modest evidence in PD and dementia, but also informed by the management of late-life depression (LLD). SUMMARY: There is evidence to guide the diagnosis and management of depression in PD or dementia. However, more research is required in this field to better inform clinical decision-making.
PURPOSE OF REVIEW: To review the available evidence for the detection and management of depression in Parkinson disease (PD) and dementia. RECENT FINDINGS:Depression is a common comorbidity in those with PD or dementia, and leads to increased morbidity. There are several available and accurate tools for the detection of depression in PD (e.g., Geriatric Depression Scale) and dementia (e.g., Cornell Scale for Depression in Dementia). Treatment of depression depends on patient preference, severity of depression, comorbidities, and available resources. Despite variable evidence, the use of nonpharmacologic strategies to manage depression is suggested. Pharmacologic management is guided by modest evidence in PD and dementia, but also informed by the management of late-life depression (LLD). SUMMARY: There is evidence to guide the diagnosis and management of depression in PD or dementia. However, more research is required in this field to better inform clinical decision-making.
Authors: Tomislav Majić; Hans Gutzmann; Andreas Heinz; Undine E Lang; Michael A Rapp Journal: Am J Geriatr Psychiatry Date: 2013-07-03 Impact factor: 4.105
Authors: Zahinoor Ismail; Luis Agüera-Ortiz; Henry Brodaty; Alicja Cieslak; Jeffrey Cummings; Corinne E Fischer; Serge Gauthier; Yonas E Geda; Nathan Herrmann; Jamila Kanji; Krista L Lanctôt; David S Miller; Moyra E Mortby; Chiadi U Onyike; Paul B Rosenberg; Eric E Smith; Gwenn S Smith; David L Sultzer; Constantine Lyketsos Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Michael A Rapp; Michal Schnaider-Beeri; Michael Wysocki; Elizabeth Guerrero-Berroa; Hillel T Grossman; Andreas Heinz; Vahram Haroutunian Journal: Am J Geriatr Psychiatry Date: 2011-04 Impact factor: 4.105
Authors: Annie Prado-Jean; Philippe Couratier; Michel Druet-Cabanac; Philippe Nubukpo; Laurence Bernard-Bourzeix; Philippe Thomas; Nicole Dechamps; Helene Videaud; Thierry Dantoine; Jean Pierre Clément Journal: Int J Geriatr Psychiatry Date: 2010-10 Impact factor: 3.485
Authors: Bruno Agustini; Mojtaba Lotfaliany; Robyn L Woods; John J McNeil; Mark R Nelson; Raj C Shah; Anne M Murray; Michael E Ernst; Christopher M Reid; Andrew Tonkin; Jessica E Lockery; Lana J Williams; Michael Berk; Mohammadreza Mohebbi Journal: J Am Geriatr Soc Date: 2020-05-13 Impact factor: 5.562
Authors: Jhielson M Pimentel; Renan C Moioli; Mariana F P de Araujo; Caetano M Ranieri; Roseli A F Romero; Frank Broz; Patricia A Vargas Journal: Front Neurorobot Date: 2021-07-01 Impact factor: 2.650